Solray-D has been specifically designed in support of patients who are working with any form of metabolic toxicity (e.g., bone loss, cardiac function, menopause, prostate/breast/colon, immune/autoimmune, pathogens, adrenal/thyroid fatigue, CFS, Fibromyalgia, Diabetes).
Vitamin D3 and Vitamin K2 (MK-7) deficiency is a world-wide epidemic. Over 1 billion people are at risk for its associated conditions beyond just this winter’s viral concerns. Almost daily, references to vitamin D dominates the headlines. Paradoxically, very little is being said about Vitamin K2. However, there is overwhelming evidence confirming that the safety of vitamin D is dependent on adequate vitamin K2 (MK-7). Vitamin K’s job is to put calcium in the right places and keep it from being deposited in the wrong places. The right places are bones and blood, and the wrong places include calcification of the vessels, bone spurs and calcification of the “soft tissues”.
Vitamin K2 (MK-7) and Vitamin D3 in Solray-D are in proper ratios to mutually support their synergistic balance requirements. 1000IU D3 requires 120mcg K2 (MK-7) to insure balance and direction.
Vitamin D deficiency has been shown to play a role in almost every major concern including:
- Breast, Prostate and Colon Cancers
- Resolves the calcium paradox
- High Blood Pressure
- Metabolic Syndrome and Diabetes
- Multiple Sclerosis
- Hormonal Imbalances
- Depression and Seasonal Affective Disorder
- Anti pathogenic (viral, bacterial, etc.)
Solray-D Nanosphere Liposome Spray: 60 ml
1 spray daily lasts 375 days Vitamin D3 1,000 IU Vitamin K2 120 mcg
5 sprays daily lasts 75 days Vitamin D3 5,000 IU Vitamin K2 600 mcg
10 sprays daily lasts 37 days Vitamin D3 10,000 IU Vitamin K2 1,200 mcg
Contraindications: Blood thinners e.g. Warfarin (Coumadin), Heparin, etc.
The commentary is not meant to diagnose, treat or replace conventional treatment, and has not been approved or reviewed by the FDA.